Summary
Bristol-Myers Squibb Company (BMY) filed an amendment to its Form 8-K (8-K/A) on October 30, 2006, specifically addressing Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). The amendment revises previously furnished supplemental financial information that was posted on the company's website and incorporated by reference into an earlier 8-K filing dated October 26, 2006. This supplemental information pertains to the company's third-quarter 2006 financial results.
Key Highlights
- 1Amendment to a previous 8-K filing (8-K/A) filed on October 30, 2006.
- 2The amendment relates to Item 2.02: Results of Operations and Financial Condition.
- 3It also updates Item 9.01: Financial Statements and Exhibits.
- 4The filing revises supplemental financial information previously posted on the BMY website (www.bms.com).
- 5This supplemental information is related to the company's third-quarter 2006 financial results.
- 6The original Form 8-K containing the press release and supplemental information was filed on October 26, 2006.
- 7Exhibit 99.2 contains the revised supplemental information.
Frequently Asked Questions
The primary purpose of this amended 8-K filing (8-K/A) is to provide revised supplemental financial information for Bristol-Myers Squibb's third-quarter 2006 results, which was originally furnished in a press release and on the company's website.
The filing specifically mentions that 'certain supplemental information posted on the Company’s website at www.bms.com' has been revised to include additional details. This information is supplementary to the press release announcing the third-quarter 2006 financial results.
The company initially reported its third-quarter 2006 financial results and furnished related information via a Form 8-K filed on October 26, 2006.
The revised supplemental financial information is furnished and incorporated by reference as Exhibit 99.2 to this Form 8-K/A filing and was also posted on the company's website at www.bms.com.